Moderna – SRK BHARAT

Moderna’s Strategic Shift Toward Oncology Therapeutics Drives Significant Market Growth

Biotechnology firm Moderna experienced a dramatic market resurgence over the past year, with its stock surging by 177 percent following a strategic pivot toward oncology development. Driven by declining revenues…

srkanalytics.srk@gmail.com August 21, 2026

Health

Moderna and Merck Advance Personalized mRNA Cancer Vaccine Trials as Shares Rise

Biotechnology firm Moderna and pharmaceutical giant Merck announced significant clinical progress in the development of their experimental messenger RNA cancer vaccine. The innovative treatment aims to target individual patient tumors…

srkanalytics.srk@gmail.com August 20, 2026

Business

Moderna Stock Surges as Melanoma Vaccine Trial Shows Landmark Moment

Biotechnology firm Moderna saw a significant surge in its stock value following the release of highly anticipated clinical trial results for a personalized messenger RNA melanoma vaccine. Developed in partnership…

srkanalytics.srk@gmail.com August 20, 2026

Health

Moderna and Merck Announce Breakthrough Results in Experimental Melanoma Vaccine Trial

Biotechnology firm Moderna and pharmaceutical giant Merck announced groundbreaking clinical trial results this week, revealing that their experimental messenger RNA (mRNA) cancer vaccine significantly reduces the risk of melanoma recurrence…

srkanalytics.srk@gmail.com August 20, 2026

Health

FDA Approves Moderna mRNA Flu Vaccine After Initial Resistance

In a notable regulatory shift, the United States Food and Drug Administration (FDA) granted approval to Moderna's messenger RNA (mRNA) seasonal influenza vaccine in Washington, D.C.This decision marks a pivotal…

srkanalytics.srk@gmail.com August 9, 2026

Health

Health Canada Approves Phase I Clinical Trial for Moderna’s mRNA Ebola Vaccine Candidate

Health Canada has officially authorized the first phase of clinical trials for Moderna's novel mRNA vaccine targeting the Bundibugyo strain of the Ebola virus. Announced by federal authorities through a…

srkanalytics.srk@gmail.com August 5, 2026